Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Hologic Inc HOLX

Healthcare Medical Devices
Hologic, Inc. is a medical technology company focused on improving women's health and well-being through early detection and treatment. It is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Diagnostics segment offers a range of diagnostic products... see more

Recent & Breaking News (NDAQ:HOLX)

Hologic Announces FDA Clearance of APTIMA Trichomonas for Use on PANTHER System

PR Newswire January 14, 2013

The Oslo Breast Cancer Screening Trial Concludes that the Use of 3D Mammography in Combination with a 2D Breast Exam Finds Significantly More Cancers than a 2D Breast Exam Alone

PR Newswire January 11, 2013

Free Research Reports on HOLX, NUVA, ROSG and TSL Issued by the Bedford Report

Marketwired January 10, 2013

The Real Story Behind NUVA, NKTR, HOLX and VOLC

Marketwired January 10, 2013

The Oslo Breast Cancer Screening Trial Concludes that the Use of 3D Mammography in Combination with a 2D Breast Exam Finds Significantly More Cancers than a 2D Breast Exam Alone

PR Newswire January 9, 2013

Hologic to Release First Quarter Fiscal 2013 Operating Results on Monday, February 4, 2013

PR Newswire January 4, 2013

Immucor to Acquire the LIFECODES(R) Business From Hologic, Inc.

Troy Schwensen January 3, 2013

Hologic Announces Sale of LIFECODES to Immucor

PR Newswire January 3, 2013

Should Recent Insider Selling on PCS, GRMN, HOLX and KLIC Matter to You?

Marketwired December 20, 2012